Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Assets
Current Assets
Cash
Prepaid expenses
Total current assets
Cash and investments held in Trust Account
Total Assets
Liabilities, Class A common stock subject to possible redemption and Stockholders' Deficit:
Current Liabilities
Accounts payable
Income taxes payable
Due to related party
Advances from Sponsor
Promissory Note – Related Party
Due to related party, net
Total current liabilities
Warrant liability
Deferred legal fee
Deferred underwriting fee
Total liabilities
Class A common stock subject to possible redemption, $0.0001 par value, 1,334,645 and 1,672,102 shares subject to possible redemption at redemption value of $10.00 per share at September 30, 2023 and December 31, 2022, respectively
Common Class A
Total class A common stock subject to possible redemption, $0.0001 par value, 1,334,645 and 1,672,102 shares subject to possible redemption at redemption value of $10.00 per share at September 30, 2023 and December 31, 2022, respectively
Stockholders' deficit:
Common stock value
Common Class A
Common Class B
Additional paid-in capital
Accumulated deficit
Common Class A
Common Class B
Total stockholders' deficit
Total liabilities, Class A common stock subject to possible redemption and stockholders' deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support